Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Behavioral Interventions to Increase Adherence to Palivizumab Prophylaxis in Children With Congenital Heart Disease: A Randomized Controlled Trial

NCT05778240 is registered in ClinicalTrials.gov with Kosuyolu Heart Hospital as lead sponsor.

NCT NCT05778240
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05778240 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Behavioral Interventions to Increase Adherence to Palivizumab Prophylaxis in Children With Congenital Heart Disease: A Randomized Controlled Trial
Lead sponsor
Kosuyolu Heart Hospital
Phase
Not applicable
Overall status
Completed
Start date
October 1, 2020
Completion date
June 1, 2021
Enrollment
229 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

congenital heart disease in children, rsv